IFAC-PapersOnLine · 2021 · 12 citations · 9 references
MedicineOncologyPharmacokineticsChemotherapyMedical OncologyPharmacokinetic ModelingComputational OncologyDose OptimizationDynamic Systems ModelingModel Predictive ControlOptimal ControlTumor Growth KineticsChemotherapy Dose OptimizationMoving Horizon EstimationNonlinear Model Predictive ControlTime-varying ParametersTumor Growth Inhibition ModelingTumor Growth ModelingVirtual Population Modeling
A Moving Horizon Estimator (MHE) based Nonlinear Model Predictive Controller (NMPC) was designed for an impulsive minimal tumor growth model. The estimator computes the time-varying model parameters using mean square error with parameter deviation penalization and provides state estimations for the controller. The controller computes optimal doses for non-equidistant, fixed time instants while constraining the administered drug dose. Tuning of the MHE was based on experimental time series measurements, while for the NMPC a virtual population was generated. The robustness of the combined approach was tested in silico on a virtual population, where the simulation was tailored to a real experimental scenario.
9
Tumor Volume Estimation and Quasi-Continuous Administration for Most Effective Bevacizumab Therapy
Johanna Sápi, Levente Kovács, Dániel András Drexler et al. · PLoS ONE · 2015 · 151 citations · Full text
Medicine, Oncology, Pharmacology +13